Sustained Release Methylphenidate

Child Psychology and Psychiatry Review

Volumn 5, Issue 3, 2000, Pages 108-113

  Ford, Tamsin ^a   Taylor, Eric ^a   Warner Rogers, Jody ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

attention deficit hyperactivity disorder; hyperkinetic disorder; methylphenidate; stimulant treatment; Sustained release

Indexed keywords

EID: 34248682473     PISSN: 13606417     EISSN: 14753588     Source Type: Journal    
DOI: 10.1017/s1360641700002264     Document Type: Article

References (18)

1. Anonymous (1984). Sustained release methylphenidate. The Medical Letter, 26, 97–98.
2. Berkovitch, M., Pope, E., Phillips, J., & Koren, G. (1995). Pemoline–associated fulminant liver failure: testing the evidence for causation. Clinical Pharmacologica Therapy, 57, 696–698
3. Birmaher, B., Greenhill, L. L., Cooper, T. B., Fried, J., & Maminski, B. (1989). Sustained release methylphenidate: pharmacokinetic studies in ADDH males. The Journal of the American Academy of Child and Adolescent Psychiatry, 28, 768–772.
4. Brown, G. L., Ebert, M. H., Mikklesen, E. J., & Hunt, R. D. (1980). Behaviour and motor activity response in hyperactive children and plasma amphetamine levels following a sustained release preparation. The Journal of the American Academy of Child and Adolescent Psychiatry, 19, 225–239.
5. Conners, C. K. (1973). Rating Scales for use in drug studies with children. Psychopharmacology Bulletin, Special issue on Pharmacotherapy in Children, 60.
6. Conners, C. K., & Taylor, E. (1980). Pemoline, methylphenidate and placebo in children with minimal brain dysfunction. Archives of General Psychiatry, 37, 922–930.
7. Douglas, V. I., Barr, R. G., Amin, K. O'Neill, M. E., & Britton, B. G. (1988). Dosage effects and individual responsivity to methylphenidate in attention deficit disorder. The Journal of Child Psychology and Psychiatry, 29, 453–475.
8. Elia, J., Ambrosini, P. J., & Rapoport, J. L. (1999). Treatment of attention deficit/ hyperactivity disorder. The New England Journal of Medicine, 340, 780–788.
9. Fitzpatrick, P. A., Klorman, R., Brumaghim, J. T., & Borgstedt, A. D. (1992). Effects of sustained release and standard methylphenidate on attention deficit disorder. The Journal of the American Academy of Child and Adolescent Psychiatry, 31, 226–234.
10. Greenhill, L. L., Cooper, T., Solomon, M., Fried, J., & Comlatt, B. (1987). Methylphenidate salivary levels in children. Psycho-pharmacology Bulletin, 23, 115–119.
11. Gualtieri, C. T., Wargin, W., Kanoy, R., Patrick, K., Shen, D., Youngblood, W., Mueller, R. A., & Breese, G. R. (1982). Clinical studies of methylphenidate in children and adults. Journal of the American Academy of Child and Adolescent Psychiatry, 21, 19–26.
12. Nehra, A., Mullick, F., Ishak, K. G., & Zimmerman, H. J. (1990). Pemoline-associated hepatic injury. Gastroenterology, 99, 1517–1519.
13. Pelham, W. E., Aronoff, H. R., Midlam, J. K., Shapiro, C. J., Gnagy, E. M., Chronis, A. M., Onyango, A. N., Forehand, G., Nguyen, A., & Waxmonsky, J. (1999). A comparison of ‘ritalin’ and ‘adderall’: Efficacy and time-course in children with attention deficit/hyperactivity disorder. Pediatrics, 103, e43.
14. Pelham Jr., W. E., Greenslade, K. E., Vodde-Hamilton, M., Murphy, D. A., Greenstein, J. J., Gnagy, E. M., Guthrie, K. J., Hoover, M.D., & Dahl, R. E. (1990). Relative efficacy of long-acting stimulants on children with attention deficit-hyper-activity disorder; a comparison of standard methylphenidate, sustained release methylphenidate, sustained release dextroamphetamine and pemoline. Pediatrics, 86, 226–237.
15. Pelham Jr., W. E., Sturges, J., Hoza, J. A., Schmidt, C, Bijlsma, J. J., Milich, R., & Moorer, S. (1987). Sustained release methylphenidate and standard methylphenidate; effects on cognitive and social behaviour in children with attention deficit disorder. Pediatrics, 80, 491–501.
16. Pelham, W. E., Swanson, J. M., Furman, M. B., & Schwindt, H. (1995). Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1504–1513.
17. Swanson, J. M., Wigal, S., Greenhill, L. L., Browne, R., Waslik, B., Lerner, M., Williams, L., Flyn, D., Agler, D., Crowley, K., Fineberg, E., Baren, M., & Cantwell, D. (1998). Analog classroom assessment of ‘Adderall’ in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 519–526.
18. Whitehouse, D., Shah, U., & Palmer, F. B. (1980). Comparison of sustained release methylphenidate and standard methylphenidate in the treatment of minimal brain dysfunction. Journal of Clinical Psychiatry, 41, 282–285.